McKesson Corporation (MCK) Financials
Key financial figures for McKesson Corporation (Q2 2027).
McKesson raised fiscal 2027 Adjusted EPS guidance to $45.60 to $46.40 from $44.20 to $45.00 after Q2 Adjusted EPS of $11.68 rose 18% from $9.86. Revenue was $111.0B (Q2 FY2027, three months ended September 30, 2026), up 8% from $103.2B a year ago, led by North American Pharmaceutical ($91.4B, +6%) and Oncology & Multispecialty ($15.0B, +24%) on higher prescription volumes and specialty distribution, partly offset by lower branded pharmaceutical contributions. GAAP diluted EPS was $10.44 versus $8.92 a year ago (+$1.52). Adjusted EPS was $11.68 versus $9.86 (+18%), which the release attributes to operating growth in three segments and a lower share count (116.7M diluted shares versus 124.4M). On the outlook: Fiscal 2027 Adjusted EPS guidance raised to $45.60 to $46.40 from the previous $44.20 to $45.00, which the company says indicates 17% to 19% growth over the prior year; McKesson does not forecast GAAP EPS. Figures are for Q2 FY2027, as McKesson Corporation reported them.
- Revenue
- $111.0B
- Net Income
- $1.2B
- EPS
- $10.47
- Total Assets
- $92.3B
- Operating Cash Flow
- $3.1B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2027 | $111.0B | $1.2B | $10.44 | 1.45% | $3.0B |
| Q1 FY2027 | $105.4B | $614M | $5.15 | 1.25% | -$332M |
| Q4 FY2026 | $96.3B | $1.7B | $13.71 | 2.23% | $3.3B |
| Q3 FY2026 | $106.2B | $1.2B | $9.59 | 1.53% | $1.1B |
| Q2 FY2026 | $103.2B | $1.1B | $8.92 | 1.36% | $2.3B |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $403.4B | $4.8B | $38.38 | 1.54% | $5.7B |
| FY2025 | $359.1B | $3.3B | $25.72 | 1.23% | $5.5B |
| FY2024 | $309.0B | $3.0B | $22.39 | 1.27% | $3.9B |
Frequently asked questions
What was McKesson Corporation's revenue last quarter?
McKesson Corporation reported revenue of $110.96 billion for Q2 FY2027, up 7.6% from the same period a year earlier.
Is McKesson Corporation profitable?
Yes. McKesson Corporation reported net income of $1.22 billion for Q2 FY2027, a net margin of 1.1% on revenue.
How has McKesson Corporation's margin trended?
Operating margin was 1.45% in Q2 FY2027. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did McKesson Corporation generate?
McKesson Corporation generated free cash flow of $3.01 billion in Q2 FY2027, after capital expenditure.
Full income statement, balance sheet and cash flow for McKesson Corporation on SentiSense, with up to forty quarters and twenty fiscal years of history.